DrugsControl Media Services
DrugsControl.org

News Detail

No Increased Risk of Suicidal Ideation With GLP-1 Drugs (09-01-2024)

North Bethesda, 8 Jan 2024: Despite recent concerns to the contrary, semaglutide (Wegovy, Ozempic) carried a lower risk of suicidal ideation in patients with obesity or type 2 diabetes, according to retrospective analyses of the two patient populations.

 

An ......
View Details

Source : Medpage Today
semaglutide (Wegovy Ozempic) lower risk of suicidal ideation type 2 diabetes Nora Volkow director of the National Institute on Drug Abuse Nature Medicine

Related News